Advanced search
Publication Cover
Leukemia & Lymphoma Volume 26, 1997 - Issue 5-6
Submit an article Journal homepage
24
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Acute Promyelocytic Leukemia in a HIV Seropositive Patient

R. Calvo Hematology Department, Hospital Universitari Germans Trim i Pujol., c/ Canyet s/n 08916 Badalona, Universitat Autdnoma of Barcelona, Spain
,
J. M. Ribera Hematology Department, Hospital Universitari Germans Trim i Pujol., c/ Canyet s/n 08916 Badalona, Universitat Autdnoma of Barcelona, Spain
,
M. Battle Hematology Department, Hospital Universitari Germans Trim i Pujol., c/ Canyet s/n 08916 Badalona, Universitat Autdnoma of Barcelona, Spain
,
J. M. Sancho Hematology Department, Hospital Universitari Germans Trim i Pujol., c/ Canyet s/n 08916 Badalona, Universitat Autdnoma of Barcelona, Spain
,
I. Granada Hematology Department, Hospital Universitari Germans Trim i Pujol., c/ Canyet s/n 08916 Badalona, Universitat Autdnoma of Barcelona, Spain
,
A. Floes Hematology Department, Hospital Universitari Germans Trim i Pujol., c/ Canyet s/n 08916 Badalona, Universitat Autdnoma of Barcelona, Spain
,
F. MillÁ Hematology Department, Hospital Universitari Germans Trim i Pujol., c/ Canyet s/n 08916 Badalona, Universitat Autdnoma of Barcelona, Spain
&
E. Feliu Hematology Department, Hospital Universitari Germans Trim i Pujol., c/ Canyet s/n 08916 Badalona, Universitat Autdnoma of Barcelona, Spain
 show all
Pages 621-624 | Accepted 22 Sep 1996, Published online: 01 Jul 2009
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Abstract

Acute myeloid leukemia (AML) is infrequent in patients with human immunodeficiency virus (HIV) infection. Among AML, acute promyelocytic leukemia (APL) has been rarely described in such patients, with only one case being published. We report a 30 years-old intravenous drug abuser HIV-infected male with APL who attained complete clinical, morphological, and molecular remission after differentiation therapy with all-trans-retinoic acid (ATRA) followed by intensive chemotherapy. The results of treatment in this patient and in other AML published cases suggest that therapy for AML should not be modified because of HIV infection if patients have an adequate performance status.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.